Tru Niagen
Asset
Boosts NAD+ levels to support cellular health.
- Stage
- Human trials
- Modality
- Supplement
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Long COVID
Human trials, niagenbioscience.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.